Hyperthermia enhances CTL cross-priming

Journal of Immunology

Volumn 176, Issue 4, 2006, Pages 2134-2141

  Shi, Hongzhen ^a   Cao, Tinghua ^a   Connolly, John E ^a   Monnet, Laurence ^a   Bennett, Lynda ^a   Chapel, Sylvie ^b   Bagnis, Claude ^b   Mannoni, Patrice ^b   Davoust, Jean ^a,c   Palucka, A Karolina ^a   Banchereau, Jacques ^a  

^a BAYLOR INSTITUTE FOR IMMUNOLOGY RESEARCH   (United States)

^b ETABLISSEMENT FRANÇAIS DU SANG   (France)

^c CNRS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CD40 LIGAND; CD8 ANTIGEN; CHROMIUM 51; COMPLEMENTARY DNA; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HEAT SHOCK PROTEIN 70; HLA A ANTIGEN; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 7; LENTIVIRUS VECTOR; RNA; SYNTHETIC PEPTIDE;

ANTIGEN PRESENTATION; ARTICLE; CD8+ T LYMPHOCYTE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CROSS PRESENTATION; CYTOTOXIC T LYMPHOCYTE; ENZYME LINKED IMMUNOSORBENT ASSAY; GENETIC TRANSDUCTION; GROWTH INHIBITION; HEAT SHOCK; HUMAN; HUMAN CELL; HYPERTHERMIA; HYPERTHERMIC THERAPY; LYMPHOCYTE DIFFERENTIATION; MELANOMA; MELANOMA CELL; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; TUMOR CELL; TUMOR GROWTH; TWO DIMENSIONAL FLUORESCENCE DIFFERENCE GEL ELECTROPHORESIS; TWO DIMENSIONAL GEL ELECTROPHORESIS;

EID: 32044456037     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.176.4.2134     Document Type: Article

References (31)

1. Woodhall, B., K. L. Pickrell, N. G. Georgiade, M. S. Mahaley, and H. T. Dukes. 1960. Effect of hyperthermia upon cancer chemotherapy: application to external cancers of head and face structures. Ann. Surg. 151: 750-759.
2. Mattson, D., C. M. Bradbury, K. S. Bisht, H. A. Curry, D. R. Spitz, and D. Gius. 2004. Heat shock and the activation of AP-1 and inhibition of NF-κB DNA-binding activity: possible role of intracellular redox status. Int. J. Hyperthermia 20: 224-233.
3. Gius, D., D. Mattson, C. M. Bradbury, D. K. Smart, and D. R. Spitz. 2004. Thermal stress and the disruption of redox-sensitive signalling and transcription factor activation: possible role in radiosensitization. Int. J. Hyperthermia 20: 213-223.
4. Milani, V., E. Noessner, S. Ghose, M. Kuppner, B. Ahrens, A. Scharner, R. Gastpar, and R. D. Issels. 2002. Heat shock protein 70: role in antigen presentation and immune stimulation. Int. J. Hyperthermia 18: 563-575.
5. Berwin, B., and C. V. Nicchitta. 2001. To find the road traveled to tumor immunity: the trafficking itineraries of molecular chaperones in antigen-presenting cells. Traffic 2: 690-697.
6. Leppa, S., and L. Sistonen. 1997. Heat shock response: pathophysiological implications. Ann. Med. 29: 73-78.
7. van Eden, W., R. van der Zee, and B. Prakken. 2005. Heat-shock proteins induce T-cell regulation of chronic inflammation. Nat. Rev. Immunol. 5: 318-330.
8. Basu, S., and P. K. Srivastava. 2000. Heat shock proteins: the fountainhead of innate and adaptive immune responses. Cell. Stress Chaperones 5: 443-451.
9. Frydman, J. 2001. Folding of newly translated proteins in vivo: the role of molecular chaperones. Annu. Rev. Biochem. 70: 603-647.
10. Srivastava, P. K., H. Udono, N. E. Blachere, and Z. Li. 1994. Heat shock proteins transfer peptides during antigen processing and CTL priming. Immunogenetics 39: 93-98.
11. Srivastava, P. 2002. Interaction of heat shock proteins with peptides and antigen presenting cells: chaperoning of the innate and adaptive immune responses. Annu. Rev. Immunol. 20: 395-425.
12. Castelli, C., A. M. Ciupitu, F. Rini, L. Rivoltini, A. Mazzocchi, R. Kiessling, and G. Parmiani. 2001. Human heat shock protein 70 peptide complexes specifically activate antimelanoma T cells. Cancer Res. 61: 222-227.
13. Noessner, E., R. Gastpar, V. Milani, A. Brandl, P. J. Hutzler, M. C. Kuppner, M. Roos, E. Kremmer, A. Asea, S. K. Calderwood, et al. 2002. Tumor-derived heat shock protein 70 peptide complexes are cross-presented by human dendritic cells. J. Immunol. 169: 5424-5432.
14. Basu, S., R. J. Binder, T. Ramalingam, and P. K. Srivastava. 2001. CD91 is a common receptor for heat shock proteins gp96, hsp90, hsp70, and calreticulin. Immunity 14: 303-313.
15. Binder, R. J., and P. K. Srivastava. 2004. Essential role of CD91 in re-presentation of gp96-chaperoned peptides. Proc. Natl. Acad. Sci. USA 101: 6128-6133.
16. Berwin, B., J. P. Hart, S. Rice, C. Gass, S. V. Pizzo, S. R. Post, and C. V. Nicchitta. 2003. Scavenger receptor-A mediates gp96/GRP94 and calreticulin internalization by antigen-presenting cells. EMBO J. 22: 6127-6136.
17. Becker, T., F. U. Hartl, and F. Wieland. 2002. CD40, an extracellular receptor for binding and uptake of Hsp70-peptide complexes. J. Cell Biol. 158: 1277-1285.
18. Delneste, Y., G. Magisirelli, J. Gauchat, J. Haeuw, J. Aubry, K. Nakamura, N. Kawakami-Honda, L. Goetsch, T. Sawamura, J. Bonnefoy, et al. 2002. Involvement of LOX-1 in dendritic cell-mediated antigen cross-presentation. Immunity 17: 353-362.
19. Asea, A., M. Rehli, E. Kabingu, J. A. Boch, O. Bare, P. E. Auron, M. A. Stevenson, and S. K. Calderwood. 2002. Novel signal transduction pathway utilized by extracellular HSP70: role of toll-like receptor (TLR) 2 and TLR4. J. Biol. Chem. 277: 15028-15034.
20. Zufferey, R., T. Dull, R. J. Mandel, A. Bukovsky, D. Quiroz, L. Naldini, and D. Trono. 1998. Self-inactivating lentivirus vector for sale and efficient in vivo gene delivery. J. Virol. 72: 9873-9880.
21. Rouas, R., R. Uch, Y. Cleuter, F. Jordier, C. Bagnis, P. Mannoni, P. Lewalle, P. Martiat, and A. Van den Broeke. 2002. Lentiviral-mediated gene delivery in human monocyte-derived dendritic cells: optimized design and procedures for highly efficient transduction compatible with clinical constraints. Cancer Gene Ther. 9: 715-724.
22. + progenitor-derived dendritic cells. J. Exp. Med. 199: 1503-1511.
23. Paczesny, S., H. Shi, H. Saito, P. Mannoni, J. Fay, J. Banchereau, and A. K. Palucka. 2005. Measuring melanoma-specific cytotoxic T lymphocytes elicited by dendritic cell vaccines with a tumor inhibition assay in vitro. J. Immunother. 28: 148-157.
24. Alban, A., S. O. David, L. Bjorkesten, C. Andersson, E. Sloge, S. Lewis, and I. Currie. 2003. A novel experimental design for comparative two-dimensional gel analysis: two-dimensional difference gel electrophoresis incorporating a pooled internal standard. Proteomics 3: 36-44.
25. Berard, F., P. Blanco, J. Davousl, E. M. Neidhart-Berard, M. Nouri-Shirazi, N. Taquet, D. Rimoldi, J. C. Cerottini, J. Banchereau, and A. K. Palucka. 2000. Cross-priming of naive CD8 T cells against melanoma antigens using dendritic cells loaded with killed allogeneic melanoma cells. J. Exp. Med. 192: 1535-1544.
26. Li, Z. 1997. Priming of T cells by heat shock protein-peptide complexes as the basis of tumor vaccines. Semin. Immunol. 9: 315-322.
27. Melcher, A., S. Todryk, N. Hardwick, M. Ford, M. Jacobson, and R. G. Vile. 1998. Tumor immunogenicity is determined by the mechanism of cell death via induction of heat shock protein expression. Nat. Med. 4: 581-587.
28. Huang, L. Q., F. Brasseur, A. Serrano, E. De Plaen, P. van der Bruggen, T. Boon, and A. Van Pel. 1999. Cytolytic T lymphocytes recognize an antigen encoded by MAGE-A10 on a human melanoma. J. Immunol. 162: 6849-6854.
29. + T cell cross-priming via transfer of proteasome substrates. Science 304: 1318-1321.
30. Castellino, F., P. E. Boucher, K. Eichelberg, M. Mayhew, J. E. Rothman, A. N. Houghton, and R. N. Germain. 2000. Receptor-mediated uptake of antigen/heat shock protein complexes results in major histocompatibility complex class 1 antigen presentation via two distinct processing pathways. J. Exp. Med. 191: 1957-1964.
31. Somersan, S., M. Larsson, J. F. Fonteneau, S. Basu, P. Srivastava, and N. Bhardwaj. 2001. Primary tumor tissue lysates are enriched in heat shock proteins and induce the maturation of human dendritic cells. J. Immunol. 167: 4844-4852.